Anzeige
Mehr »
Login
Mittwoch, 16.10.2024 Börsentäglich über 12.000 News von 676 internationalen Medien
7 neue Bohrlöcher bei Best Chance: Gladiator Metals (WKN: A3D6HK) bereit für ein Ressourcen-Update
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PN0J | ISIN: US70014A1043 | Ticker-Symbol: PKE
Frankfurt
16.10.24
08:20 Uhr
12,000 Euro
0,000
0,00 %
Branche
Luftfahrt/Rüstung
Aktienmarkt
Sonstige
1-Jahres-Chart
PARK AEROSPACE CORP Chart 1 Jahr
5-Tage-Chart
PARK AEROSPACE CORP 5-Tage-Chart
RealtimeGeldBriefZeit
12,10012,80014:25
GlobeNewswire (Europe)
37 Leser
Artikel bewerten:
(0)

Park Aerospace Corp. Reports Second Quarter Results

NEWTON, Kan., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Park Aerospace Corp. (NYSE-PKE) reported results for the 2025 fiscal year second quarter ended September 1, 2024. The Company will conduct a conference call to discuss its financial results and other matters at 5:00 p.m. EDT today. A live audio webcast of the event, along with presentation materials, will be available at https://edge.media-server.com/mmc/p/yikc26i5 at 5:00 p.m. EDT today. The presentation materials will also be available at approximately 4:15 p.m. EDT today at https://parkaerospace.com/shareholders/investor-conference-calls/ and on the Company's website at www.parkaerospace.com under "Investor Conference Calls" on the "Shareholders" page.

Park reported net sales of $16,709,000 for the 2025 fiscal year second quarter ended September 1, 2024 compared to $12,481,000 for the 2024 fiscal year second quarter ended August 27, 2023 and $13,970,000 for the 2025 fiscal year first quarter ended June 2, 2024. Park's net sales for the six months ended September 1, 2024 were $30,679,000 compared to $28,032,000 for the six months ended August 27, 2023. Net earnings for the 2025 fiscal year second quarter were $2,066,000 compared to $1,746,000 for the 2024 fiscal year second quarter and $993,000 for the 2025 fiscal year first quarter. Net earnings were $3,059,000 for the current year's first six months compared to $3,600,000 for last year's first six months.

Net earnings before special items for the 2025 fiscal year second quarter were $2,092,000 compared to $1,746,000 for the 2024 fiscal year second quarter and $1,781,000 for the 2025 fiscal year first quarter. Net earnings before special items for the six months ended September 1, 2024 were $3,873,000 compared to $4,153,000 for last fiscal year's first six months.

Adjusted EBITDA for the 2025 fiscal year second quarter was $3,206,000 compared to $2,669,000 for the 2024 fiscal year second quarter and $2,610,000 for the 2025 fiscal year first quarter. Adjusted EBITDA for the current year's first six months was $5,816,000 compared to $5,980,000 for last year's first six months.

During the 2025 fiscal year second quarter and first six months, respectively, the Company recorded $46,000 and $1,098,000 of pre-tax charges related to storm damage to the Company's facilities in Newton Kansas. During the 2024 fiscal year's first six months, the Company recorded $570,000 of pre-tax activist shareholder defense costs, $65,000 of pre-tax losses on sales of investments to fund the $1.00 per share special dividend paid on April 6, 2023 to shareholders of record on March 9, 2023 and a $109,000 pre-tax charge for the modification of previously granted stock options in connection with the special dividend in the 2024 fiscal year first quarter.

Park reported basic and diluted earnings per share of $0.10 for the 2025 fiscal year second quarter compared to $0.09 for the 2024 fiscal year second quarter and $0.05 for the 2025 fiscal year first quarter. Basic and diluted earnings per share before special items were $0.10 for the 2025 fiscal year second quarter compared to $0.09 for the 2024 fiscal year second quarter and $0.09 for the 2025 fiscal year first quarter.

Park reported basic and diluted earnings per share of $0.15 for the 2025 fiscal year's first six months compared to $0.18 for the 2024 fiscal year's first six months. Basic and diluted earnings per share before special items were $0.19 for the 2025 fiscal year's first six months compared to $0.20 for the 2024 fiscal year's first six months.

The Company will conduct a conference call to discuss its financial results at 5:00 p.m. EDT today. Forward-looking and other material information may be discussed in this conference call. The conference call dial-in number is (877) 407-3982 in the United States and Canada, and (201) 493-6780 in other countries. The required passcode for attendance by phone is 13749480.

For those unable to listen to the call live, a conference call replay will be available from approximately 8:00 p.m. EDT today through 11:59 p.m. EDT on Tuesday, October 22, 2024. The conference call replay will be available at https://edge.media-server.com/mmc/p/yikc26i5 and on the Company's website at www.parkaerospace.com under "Investor Conference Calls" on the "Shareholders" page. It can also be accessed by dialing (844) 512-2921 in the United States and Canada, and (412) 317-6671 in other countries. The required passcode for accessing the replay by phone is 13749480.

Any additional material financial or statistical data disclosed in the conference call, including the investor presentation, will also be available at the time of the conference call on the Company's website at
https://parkaerospace.com/shareholders/investor-conference-calls/.

Park believes that an evaluation of its ongoing operations would be difficult if the disclosure of its operating results were limited to accounting principles generally accepted in the United States of America ("GAAP") financial measures, which include special items, such as a charge related to storm damage, activist shareholder defense costs, losses on sales of investments and charges for modification of previously granted stock options. Accordingly, in addition to disclosing its operating results determined in accordance with GAAP, Park discloses non-GAAP measures, including Adjusted EBITDA, and operating results that exclude special items in order to assist its shareholders and other readers in assessing the Company's operating performance, since the Company's on-going, normal business operations do not include such special items. The detailed operating information presented below includes a reconciliation of the non-GAAP operating results before special items to earnings determined in accordance with GAAP and a reconciliation of GAAP pre-tax earnings to Adjusted EBITDA. Such non-GAAP financial measures are provided to supplement the results provided in accordance with GAAP.

Park Aerospace Corp. develops and manufactures solution and hot-melt advanced composite materials used to produce composite structures for the global aerospace markets. Park's advanced composite materials include film adhesives (Aeroadhere®) and lightning strike protection materials (Electroglide®). Park offers an array of composite materials specifically designed for hand lay-up or automated fiber placement (AFP) manufacturing applications. Park's advanced composite materials are used to produce primary and secondary structures for jet engines, large and regional transport aircraft, military aircraft, Unmanned Aerial Vehicles (UAVs commonly referred to as "drones"), business jets, general aviation aircraft and rotary wing aircraft. Park also offers specialty ablative materials for rocket motors and nozzles and specially designed materials for radome applications. As a complement to Park's advanced composite materials offering, Park designs and fabricates composite parts, structures and assemblies and low volume tooling for the aerospace industry. Target markets for Park's composite parts and structures (which include Park's proprietary composite SigmaStrut and AlphaStrut product lines) are, among others, prototype and development aircraft, special mission aircraft, spares for legacy military and civilian aircraft and exotic spacecraft. Park's objective is to do what others are either unwilling or unable to do. When nobody else wants to do it because it is too difficult, too small or too annoying, sign us up.

Additional corporate information is available on the Company's website at www.parkaerospace.com

Performance table, including non-GAAP information (in thousands, except per share amounts - unaudited):

13 Weeks Ended 13 Weeks Ended 13 Weeks Ended 26 Weeks Ended
September 1, 2024 August 27, 2023 June 2, 2024 September 1, 2024 August 27, 2023
Sales$16,709 $12,481 $13,970 $30,679 $28,032
Net Earnings before Special Items1$2,092 $1,746 $1,781 $3,873 $4,153
Special Items, Net of Tax:
Activist Shareholder Defense Costs - - - - (570)
Stock Option Modification - - - - (109)
Loss on Sale of Marketable Securities - - - - (65)
Storm Damage Charge (46) - (1,052) (1,098) -
Income Tax Effect on Pretax Special Items 20 - 264 284 191
Net Earnings$2,066 $1,746 $993 $3,059 $3,600
Basic Earnings per Share:
Basic Earnings before Special Items1$0.10 $0.09 $0.09 $0.19 $0.20
Special Items:
Activist Shareholder Defense Costs - - - - (0.03)
Stock Option Modification - - - - -
Loss on Sale of Marketable Securities - - - - -
Storm Damage Charge - - (0.05) (0.05) -
Income Tax Effect on Pretax Special Items - - 0.01 0.01 0.01
Basic Earnings per Share$0.10 $0.09 $0.05 $0.15 $0.18
Diluted Earnings before Special Items1$0.10 $0.09 $0.09 $0.19 $0.20
Special Items:
Activist Shareholder Defense Costs - - - - (0.03)
Stock Option Modification - - - - -
Loss on Sale of Marketable Securities - - - - -
Storm Damage Charge - - (0.05) (0.05) -
Income Tax Effect on Pretax Special Items - - 0.01 0.01 0.01
Diluted Earnings per Share$0.10 $0.09 $0.05 $0.15 $0.18
Weighted Average Shares Outstanding:
Basic 20,216 20,256 20,253 20,234 20,359
Diluted 20,291 20,338 20,371 20,331 20,432
1Refer to "Reconciliation of non-GAAP financial measures" below for information regarding Special Items.

Comparative balance sheets (in thousands):

September 1, 2024 March 3, 2024
Assets(unaudited)
Current Assets
Cash and Marketable Securities$71,984 $77,211
Accounts Receivable, Net 10,914 12,381
Inventories 7,630 6,404
Prepaid Expenses and Other Current Assets 2,499 2,849
Total Current Assets 93,027 98,845
Fixed Assets, Net 21,891 23,499
Operating Right-of-use Assets 334 95
Other Assets 9,863 9,870
Total Assets$125,115 $132,309
Liabilities and Shareholders' Equity
Current Liabilities
Accounts Payable$3,700 $3,514
Accrued Liabilities 1,348 1,986
Operating Lease Liability 40 53
Income Taxes Payable 5,121 4,105
Total Current Liabilities 10,209 9,658
Long-term Operating Lease Liability 339 82
Non-current Income Taxes Payable - 5,259
Deferred Income Taxes 3,087 3,222
Other Liabilities 1,222 1,174
Total Liabilities 14,857 19,395
Shareholders' Equity 110,258 112,914
Total Liabilities and Shareholders' Equity$125,115 $132,309
Additional information
Equity per Share$5.48 $5.58

Comparative statements of operations (in thousands - unaudited):

13 Weeks Ended 13 Weeks Ended 13 Weeks Ended 26 Weeks Ended
September 1, 2024 August 27, 2023 June 2, 2024 September 1, 2024 August 27, 2023
Net Sales$16,709 $12,481 $13,970 $30,679 $28,032
Cost of Sales 11,952 8,402 9,871 21,823 19,120
Gross Profit 4,757 4,079 4,099 8,856 8,912
% of net sales 28.5% 32.7% 29.3% 28.9% 31.8%
Selling, General & Administrative Expenses 2,140 1,853 2,017 4,157 4,468
% of net sales 12.8% 14.8% 14.4% 13.5% 15.9%
Earnings from Operations 2,617 2,226 2,082 4,699 4,444
Storm Damage Charge (46) - (1,052) (1,098) -
Interest and Other Income:
Interest Income 245 139 339 584 463
Earnings from Operations before Income Taxes 2,816 2,365 1,369 4,185 4,907
Income Tax Provision 750 619 376 1,126 1,307
Net Earnings$2,066 $1,746 $993 $3,059 $3,600
% of net sales 12.4% 14.0% 7.1% 10.0% 12.8%

Reconciliation of non-GAAP financial measures (in thousands - unaudited):

Reconciliation of GAAP Net Earnings to Adjusted EBITDA
13 Weeks Ended 13 Weeks Ended 13 Weeks Ended 26 Weeks Ended 26 Weeks Ended
September 1, 2024 August 27, 2023 June 2, 2024 September 1, 2024 August 27, 2023
GAAP Net Earnings$2,066 $1,746 $993 $3,059 $3,600
Adjustments:
Income Tax Provision 750 619 376 1,126 1,307
Interest Income (245) (139) (339) (584) (528)
Depreciation 488 339 439 927 644
Stock Option Expense 101 104 89 190 213
Special Items:
Activist Shareholder Defense Costs - - - - 570
Stock Option Modification Charge (a) - - - - 109
Pre-tax Losses on Sales of Investments (b) - - - - 65
Storm Damage Charge 46 - 1,052 1,098 -
Adjusted EBITDA$3,206 $2,669 $2,610 $5,816 $5,980
(a) pre-tax charge for the modification of previously granted stock options in connection with the special dividend in the 2024 fiscal year first quarter
(b) to fund the $1.00 per share special dividend paid on April 6, 2023 to shareholders of record on March 9, 2023
Contact: Donna D'Amico-Annitto486 North Oliver Road, Bldg. Z
Newton, Kansas 67114
(316) 283-6500

© 2024 GlobeNewswire (Europe)
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.